Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review

Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review

Wei Shang,1,&ast; Xin-Hui Li,2,&ast; Lang-Hong Zeng,2,&ast; Zhi Li,3 Yu Hu,2 Hui-Min Wen,2 Feng-Jun Cao,2 Guo-Xing Wan2 1Department of Orthopedics, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, People’s Republic of China; 2Department of Oncology, Renmin Hospi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shang W, Li XH, Zeng LH, Li Z, Hu Y, Wen HM, Cao FJ, Wan GX
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-07-01
Series:	Drug Design, Development and Therapy
Subjects:	doxorubicin cardiotoxicity flavonoids mechanism cardioprotection
Online Access:	https://www.dovepress.com/mechanistic-insights-into-flavonoid-subclasses-as-cardioprotective-age-peer-reviewed-fulltext-article-DDDT
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity
by: Hamdi Nsairat, et al.
Published: (2025-08-01)

Combined effects of metformin and coenzyme Q10 on doxorubicin-induced cardiotoxicity in male wistar rats
by: Faraz Mahdizadeh, et al.
Published: (2025-07-01)

CARDIOPROTECTIVE EFFECT OF TUMOR NECROSIS FACTOR ALPHA ANTAGONIST IN DOXORUBICIN MYOCARD TOXICITY
by: M. I. Popovich, et al.
Published: (2018-02-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Biomarkers of chemotherapy-induced cardiotoxicity: toward precision prevention using extracellular vesicles
by: Brian B. Silver, et al.
Published: (2024-04-01)

A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity
by: Hadi Zare-Zardini, et al.
Published: (2024-12-01)

Cell-Permeable Microprotein from Panax Ginseng Protects Against Doxorubicin-Induced Oxidative Stress and Cardiotoxicity
by: Bamaprasad Dutta, et al.
Published: (2025-04-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01)

Cardiotoxicity in chemotherapeutic agents
by: Vitorino Modesto dos Santos, et al.
Published: (2021-03-01)

Metabolomic profiling and biomarker identification for early detection and therapeutic targeting of doxorubicin-induced cardiotoxicity
by: Jingjing Ding, et al.
Published: (2025-04-01)

Cardioprotective effect of Saussurea involucrata injection against Doxorubicin-induced cardiotoxicity by network pharmacology analysis and experimental verification
by: Wang Ding, et al.
Published: (2024-12-01)

The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism
by: Shuai Shi, et al.
Published: (2025-07-01)

Clinicopathological Studies on the Impact of Grape Seed Extract and L-Carnitine as Cardioprotective Agents Against Doxorubicin-Induced Toxicity in Rats
by: Tahany Saleh Aldayel, et al.
Published: (2024-12-01)

Cardiotoxic and Cardioprotective Effects of Methylene Blue in the Animal Model of Cardiac Ischemia and Reperfusion
by: Hezio Jadir Fernandes Junior, et al.
Published: (2024-11-01)

Promising Mesenchymal Stem Cell Intervention for Relieving Cardiac Recovery against Cardiotoxic Injury Modeling with Doxorubicin: A Novel Therapeutic Approach
by: Ozgermen Deva Basak Boztok, et al.
Published: (2025-06-01)

Evaluating cardioprotective strategies for anthracycline-induced cardiotoxicity in breast cancer: insights from a systematic review and network meta-analysis
by: Runyu Liu, et al.
Published: (2025-07-01)

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
by: John Lee, et al.
Published: (2024-12-01)

Mitochondrial Amount Determines Doxorubicin‐Induced Cardiotoxicity in Cardiomyocytes
by: Weiyao Xiong, et al.
Published: (2025-03-01)

Photobiomodulation Therapy Reduces Oxidative Stress and Inflammation to Alleviate the Cardiotoxic Effects of Doxorubicin in Human Stem Cell-Derived Ventricular Cardiomyocytes
by: Guilherme Rabelo Nasuk, et al.
Published: (2025-07-01)

The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
by: D. A. Andreev, et al.
Published: (2024-03-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Research on Doxorubicin-Induced Cardiotoxicity Mechanism and Its Forensic Application
by: ZHANG Shuai, et al.
Published: (2025-04-01)

5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth
by: Xinning Guo, et al.
Published: (2025-09-01)

Bioinformatics analysis of ferroptosis-related biomarkers and potential drug predictions in doxorubicin-induced cardiotoxicity
by: Jian Yu, et al.
Published: (2025-04-01)

Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study
by: Noora Alyasari, et al.
Published: (2023-12-01)

Serum and plasma sphingolipids as biomarkers of chemotherapy-induced cardiotoxicity in female patients with breast cancer
by: Samia Mohammed, et al.
Published: (2025-05-01)

Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes
by: Xiaowen Shi, et al.
Published: (2024-12-01)

Non-Coding RNAs in the Regulation of Doxorubicin-Induced Cardiotoxicity
by: Mengyao Sun, et al.
Published: (2025-05-01)

C leistopholis patens root bark extract exerts cardioprotective effect against doxorubicin-induced myocardial toxicity in rats
by: Chidinma Pamela Ononiwu, et al.
Published: (2024-11-01)

Tetrahedral Framework Nucleic Acids Inhibit Oxidative Stress and Cardiomyocyte Apoptosis in Doxorubicin-Induced Cardiotoxicity
by: Pan H, et al.
Published: (2025-07-01)

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022-03-01)

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis
by: Christopher W. Hoeger, et al.
Published: (2025-07-01)

Longitudinal Assessment of QT Apex in Tumor‐Bearing Dogs Receiving Doxorubicin Monotherapy
by: Keita Kitagawa, et al.
Published: (2025-07-01)

PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer
by: Bingting Li, et al.
Published: (2023-12-01)

Diacylglycerol Kinase ζ Attenuates Doxorubicin‐Induced Cardiotoxicity Through p53 Degradation
by: Shingo Tachibana, et al.
Published: (2025-01-01)

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
by: Atefeh Ghahremanloo, et al.
Published: (2025-03-01)

Role of mitochondrial fusion in doxorubicin-induced cardiotoxicity
by: WANG Yuqi, WANG Xinyu, LUO Haowen, LU Zhaoxin, ZHAO Yiwei, CHANG Pan
Published: (2025-01-01)

Apelinergic System Affects Electrocardiographic Abnormalities Induced by Doxorubicin
by: Kasper Buczma, et al.
Published: (2025-01-01)